Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risankizumab in Psoriasis with Autoreactive T-cells
NCT04722640Phase 4Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of risankizumab in psoriasis, sponsored by Humanitas Research Hospital. Status: unknown.
02
Drugs
risankizumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT04722640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04722640.